nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Thiotepa—sarcoma	0.15	0.458	CbGbCtD
Alfuzosin—CYP3A4—Mitoxantrone—sarcoma	0.0646	0.197	CbGbCtD
Alfuzosin—CYP3A4—Vincristine—sarcoma	0.0445	0.136	CbGbCtD
Alfuzosin—CYP3A4—Etoposide—sarcoma	0.0408	0.124	CbGbCtD
Alfuzosin—CYP3A4—Doxorubicin—sarcoma	0.0278	0.0847	CbGbCtD
Alfuzosin—Angiopathy—Etoposide—sarcoma	0.00235	0.0035	CcSEcCtD
Alfuzosin—Mediastinal disorder—Etoposide—sarcoma	0.00234	0.00348	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00234	0.00348	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00232	0.00345	CcSEcCtD
Alfuzosin—Arthralgia—Mitoxantrone—sarcoma	0.00231	0.00344	CcSEcCtD
Alfuzosin—Chest pain—Mitoxantrone—sarcoma	0.00231	0.00344	CcSEcCtD
Alfuzosin—Discomfort—Mitoxantrone—sarcoma	0.00228	0.0034	CcSEcCtD
Alfuzosin—Somnolence—Thiotepa—sarcoma	0.00228	0.00339	CcSEcCtD
Alfuzosin—Oedema—Vincristine—sarcoma	0.00227	0.00338	CcSEcCtD
Alfuzosin—Infection—Vincristine—sarcoma	0.00226	0.00336	CcSEcCtD
Alfuzosin—Dyspepsia—Thiotepa—sarcoma	0.00226	0.00336	CcSEcCtD
Alfuzosin—Nervous system disorder—Vincristine—sarcoma	0.00223	0.00332	CcSEcCtD
Alfuzosin—Thrombocytopenia—Vincristine—sarcoma	0.00223	0.00331	CcSEcCtD
Alfuzosin—Oedema—Mitoxantrone—sarcoma	0.00222	0.0033	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Thiotepa—sarcoma	0.00221	0.0033	CcSEcCtD
Alfuzosin—Fatigue—Thiotepa—sarcoma	0.00221	0.00329	CcSEcCtD
Alfuzosin—Infection—Mitoxantrone—sarcoma	0.0022	0.00327	CcSEcCtD
Alfuzosin—Hyperhidrosis—Vincristine—sarcoma	0.0022	0.00327	CcSEcCtD
Alfuzosin—Fatigue—Dactinomycin—sarcoma	0.00219	0.00327	CcSEcCtD
Alfuzosin—Pain—Thiotepa—sarcoma	0.00219	0.00326	CcSEcCtD
Alfuzosin—Constipation—Thiotepa—sarcoma	0.00219	0.00326	CcSEcCtD
Alfuzosin—Back pain—Etoposide—sarcoma	0.00218	0.00325	CcSEcCtD
Alfuzosin—Shock—Mitoxantrone—sarcoma	0.00218	0.00324	CcSEcCtD
Alfuzosin—Pain—Dactinomycin—sarcoma	0.00218	0.00324	CcSEcCtD
Alfuzosin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00217	0.00323	CcSEcCtD
Alfuzosin—Tachycardia—Mitoxantrone—sarcoma	0.00216	0.00322	CcSEcCtD
Alfuzosin—Skin disorder—Mitoxantrone—sarcoma	0.00215	0.0032	CcSEcCtD
Alfuzosin—Hyperhidrosis—Mitoxantrone—sarcoma	0.00214	0.00319	CcSEcCtD
Alfuzosin—Hypotension—Vincristine—sarcoma	0.00213	0.00316	CcSEcCtD
Alfuzosin—Feeling abnormal—Thiotepa—sarcoma	0.00211	0.00315	CcSEcCtD
Alfuzosin—Osteoarthritis—Epirubicin—sarcoma	0.0021	0.00313	CcSEcCtD
Alfuzosin—Feeling abnormal—Dactinomycin—sarcoma	0.0021	0.00312	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Thiotepa—sarcoma	0.0021	0.00312	CcSEcCtD
Alfuzosin—Ill-defined disorder—Etoposide—sarcoma	0.00209	0.00312	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00208	0.0031	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Vincristine—sarcoma	0.00207	0.00308	CcSEcCtD
Alfuzosin—Hypotension—Mitoxantrone—sarcoma	0.00207	0.00308	CcSEcCtD
Alfuzosin—Urticaria—Thiotepa—sarcoma	0.00204	0.00303	CcSEcCtD
Alfuzosin—Malaise—Etoposide—sarcoma	0.00204	0.00303	CcSEcCtD
Alfuzosin—Vertigo—Etoposide—sarcoma	0.00203	0.00302	CcSEcCtD
Alfuzosin—Abdominal pain—Thiotepa—sarcoma	0.00203	0.00302	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00202	0.003	CcSEcCtD
Alfuzosin—Abdominal pain—Dactinomycin—sarcoma	0.00201	0.00299	CcSEcCtD
Alfuzosin—Loss of consciousness—Etoposide—sarcoma	0.00198	0.00295	CcSEcCtD
Alfuzosin—Somnolence—Mitoxantrone—sarcoma	0.00197	0.00293	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Vincristine—sarcoma	0.00196	0.00292	CcSEcCtD
Alfuzosin—Fatigue—Vincristine—sarcoma	0.00196	0.00292	CcSEcCtD
Alfuzosin—Dyspepsia—Mitoxantrone—sarcoma	0.00195	0.0029	CcSEcCtD
Alfuzosin—Pain—Vincristine—sarcoma	0.00195	0.00289	CcSEcCtD
Alfuzosin—Constipation—Vincristine—sarcoma	0.00195	0.00289	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—sarcoma	0.00194	0.00289	CcSEcCtD
Alfuzosin—Chest pain—Etoposide—sarcoma	0.00192	0.00286	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—sarcoma	0.00192	0.00286	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—sarcoma	0.00192	0.00286	CcSEcCtD
Alfuzosin—Fatigue—Mitoxantrone—sarcoma	0.00191	0.00284	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00191	0.00284	CcSEcCtD
Alfuzosin—Discomfort—Etoposide—sarcoma	0.0019	0.00283	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—sarcoma	0.0019	0.00283	CcSEcCtD
Alfuzosin—Pain—Mitoxantrone—sarcoma	0.00189	0.00282	CcSEcCtD
Alfuzosin—Constipation—Mitoxantrone—sarcoma	0.00189	0.00282	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00189	0.00282	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vincristine—sarcoma	0.00186	0.00277	CcSEcCtD
Alfuzosin—Asthenia—Thiotepa—sarcoma	0.00184	0.00274	CcSEcCtD
Alfuzosin—Infection—Etoposide—sarcoma	0.00183	0.00272	CcSEcCtD
Alfuzosin—Asthenia—Dactinomycin—sarcoma	0.00183	0.00272	CcSEcCtD
Alfuzosin—Feeling abnormal—Mitoxantrone—sarcoma	0.00183	0.00272	CcSEcCtD
Alfuzosin—Pruritus—Thiotepa—sarcoma	0.00181	0.0027	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00181	0.0027	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—sarcoma	0.0018	0.00268	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—sarcoma	0.0018	0.00268	CcSEcCtD
Alfuzosin—Abdominal pain—Vincristine—sarcoma	0.0018	0.00268	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—sarcoma	0.00179	0.00266	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—sarcoma	0.00178	0.00265	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—sarcoma	0.00178	0.00264	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—sarcoma	0.00178	0.00264	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—sarcoma	0.00177	0.00263	CcSEcCtD
Alfuzosin—Urticaria—Mitoxantrone—sarcoma	0.00176	0.00262	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—sarcoma	0.00176	0.00261	CcSEcCtD
Alfuzosin—Diarrhoea—Thiotepa—sarcoma	0.00176	0.00261	CcSEcCtD
Alfuzosin—Abdominal pain—Mitoxantrone—sarcoma	0.00175	0.00261	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00175	0.00261	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—sarcoma	0.00175	0.0026	CcSEcCtD
Alfuzosin—Diarrhoea—Dactinomycin—sarcoma	0.00174	0.00259	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—sarcoma	0.00172	0.00256	CcSEcCtD
Alfuzosin—Dizziness—Thiotepa—sarcoma	0.0017	0.00252	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—sarcoma	0.00169	0.00251	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—sarcoma	0.00164	0.00244	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—sarcoma	0.00164	0.00244	CcSEcCtD
Alfuzosin—Asthenia—Vincristine—sarcoma	0.00163	0.00243	CcSEcCtD
Alfuzosin—Vomiting—Thiotepa—sarcoma	0.00163	0.00243	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—sarcoma	0.00162	0.00241	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—sarcoma	0.00162	0.00241	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—sarcoma	0.00162	0.00241	CcSEcCtD
Alfuzosin—Vomiting—Dactinomycin—sarcoma	0.00162	0.00241	CcSEcCtD
Alfuzosin—Rash—Thiotepa—sarcoma	0.00162	0.00241	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—sarcoma	0.00162	0.00241	CcSEcCtD
Alfuzosin—Dermatitis—Thiotepa—sarcoma	0.00162	0.0024	CcSEcCtD
Alfuzosin—Headache—Thiotepa—sarcoma	0.00161	0.00239	CcSEcCtD
Alfuzosin—Rash—Dactinomycin—sarcoma	0.00161	0.00239	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—sarcoma	0.00159	0.00237	CcSEcCtD
Alfuzosin—Asthenia—Mitoxantrone—sarcoma	0.00159	0.00237	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—sarcoma	0.00159	0.00236	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—sarcoma	0.00159	0.00236	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—sarcoma	0.00158	0.00235	CcSEcCtD
Alfuzosin—Constipation—Etoposide—sarcoma	0.00158	0.00234	CcSEcCtD
Alfuzosin—Pain—Etoposide—sarcoma	0.00158	0.00234	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00156	0.00232	CcSEcCtD
Alfuzosin—Diarrhoea—Vincristine—sarcoma	0.00156	0.00232	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—sarcoma	0.00155	0.00231	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—sarcoma	0.00153	0.00228	CcSEcCtD
Alfuzosin—Nausea—Thiotepa—sarcoma	0.00152	0.00227	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—sarcoma	0.00152	0.00226	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—sarcoma	0.00152	0.00226	CcSEcCtD
Alfuzosin—Diarrhoea—Mitoxantrone—sarcoma	0.00152	0.00226	CcSEcCtD
Alfuzosin—Nausea—Dactinomycin—sarcoma	0.00151	0.00225	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—sarcoma	0.00151	0.00224	CcSEcCtD
Alfuzosin—Dizziness—Vincristine—sarcoma	0.0015	0.00224	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—sarcoma	0.0015	0.00223	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—sarcoma	0.0015	0.00223	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—sarcoma	0.0015	0.00223	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—sarcoma	0.00147	0.00219	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—sarcoma	0.00146	0.00218	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—sarcoma	0.00146	0.00217	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—sarcoma	0.00146	0.00217	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—sarcoma	0.00146	0.00217	CcSEcCtD
Alfuzosin—Vomiting—Vincristine—sarcoma	0.00145	0.00215	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—sarcoma	0.00144	0.00215	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—sarcoma	0.00144	0.00214	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—sarcoma	0.00144	0.00214	CcSEcCtD
Alfuzosin—Rash—Vincristine—sarcoma	0.00143	0.00213	CcSEcCtD
Alfuzosin—Dermatitis—Vincristine—sarcoma	0.00143	0.00213	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—sarcoma	0.00143	0.00213	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—sarcoma	0.00143	0.00212	CcSEcCtD
Alfuzosin—Headache—Vincristine—sarcoma	0.00142	0.00212	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—sarcoma	0.00142	0.00211	CcSEcCtD
Alfuzosin—Vomiting—Mitoxantrone—sarcoma	0.00141	0.0021	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—sarcoma	0.00141	0.00209	CcSEcCtD
Alfuzosin—Rash—Mitoxantrone—sarcoma	0.0014	0.00208	CcSEcCtD
Alfuzosin—Dermatitis—Mitoxantrone—sarcoma	0.0014	0.00208	CcSEcCtD
Alfuzosin—Headache—Mitoxantrone—sarcoma	0.00139	0.00207	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—sarcoma	0.00136	0.00202	CcSEcCtD
Alfuzosin—Nausea—Vincristine—sarcoma	0.00135	0.00201	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—sarcoma	0.00135	0.00201	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—sarcoma	0.00135	0.00201	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—sarcoma	0.00135	0.00201	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—sarcoma	0.00134	0.00199	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—sarcoma	0.00133	0.00198	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—sarcoma	0.00132	0.00197	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—sarcoma	0.00132	0.00197	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—sarcoma	0.00132	0.00196	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—sarcoma	0.00132	0.00196	CcSEcCtD
Alfuzosin—Nausea—Mitoxantrone—sarcoma	0.00132	0.00196	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—sarcoma	0.00131	0.00195	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—sarcoma	0.0013	0.00194	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—sarcoma	0.00127	0.0019	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—sarcoma	0.00126	0.00188	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—sarcoma	0.00126	0.00187	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—sarcoma	0.00125	0.00186	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—sarcoma	0.00125	0.00186	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—sarcoma	0.00122	0.00182	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—sarcoma	0.00122	0.00182	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—sarcoma	0.00122	0.00181	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—sarcoma	0.00121	0.0018	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—sarcoma	0.00118	0.00175	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—sarcoma	0.00117	0.00175	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—sarcoma	0.00117	0.00174	CcSEcCtD
Alfuzosin—Rash—Etoposide—sarcoma	0.00116	0.00173	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—sarcoma	0.00116	0.00173	CcSEcCtD
Alfuzosin—Headache—Etoposide—sarcoma	0.00115	0.00172	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—sarcoma	0.00114	0.0017	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—sarcoma	0.00114	0.00169	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—sarcoma	0.00113	0.00169	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—sarcoma	0.00113	0.00169	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—sarcoma	0.00112	0.00166	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—sarcoma	0.00111	0.00166	CcSEcCtD
Alfuzosin—Nausea—Etoposide—sarcoma	0.00109	0.00163	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—sarcoma	0.00109	0.00162	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—sarcoma	0.00108	0.0016	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—sarcoma	0.00108	0.0016	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00107	0.00159	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—sarcoma	0.00106	0.00158	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—sarcoma	0.00106	0.00157	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—sarcoma	0.00105	0.00157	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—sarcoma	0.00105	0.00157	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—sarcoma	0.00105	0.00156	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—sarcoma	0.00103	0.00154	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—sarcoma	0.00103	0.00154	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—sarcoma	0.00103	0.00153	CcSEcCtD
Alfuzosin—Infection—Epirubicin—sarcoma	0.00103	0.00153	CcSEcCtD
Alfuzosin—Shock—Epirubicin—sarcoma	0.00102	0.00151	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—sarcoma	0.00101	0.00151	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—sarcoma	0.00101	0.0015	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—sarcoma	0.00101	0.0015	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—sarcoma	0.001	0.00149	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—sarcoma	0.000998	0.00149	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—sarcoma	0.000997	0.00148	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—sarcoma	0.000997	0.00148	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00099	0.00147	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—sarcoma	0.000985	0.00147	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—sarcoma	0.000975	0.00145	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—sarcoma	0.000965	0.00144	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—sarcoma	0.000956	0.00142	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—sarcoma	0.000949	0.00141	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000941	0.0014	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—sarcoma	0.00094	0.0014	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—sarcoma	0.000937	0.00139	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—sarcoma	0.000936	0.00139	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—sarcoma	0.000933	0.00139	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—sarcoma	0.000928	0.00138	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—sarcoma	0.000924	0.00137	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—sarcoma	0.000918	0.00137	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—sarcoma	0.000909	0.00135	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—sarcoma	0.000893	0.00133	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000892	0.00133	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—sarcoma	0.00089	0.00133	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—sarcoma	0.000883	0.00131	CcSEcCtD
Alfuzosin—Pain—Epirubicin—sarcoma	0.000883	0.00131	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000871	0.0013	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—sarcoma	0.000851	0.00127	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—sarcoma	0.00085	0.00126	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—sarcoma	0.000845	0.00126	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—sarcoma	0.000841	0.00125	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000825	0.00123	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—sarcoma	0.000824	0.00123	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—sarcoma	0.00082	0.00122	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—sarcoma	0.000817	0.00122	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—sarcoma	0.000817	0.00122	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—sarcoma	0.000816	0.00121	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—sarcoma	0.000788	0.00117	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000781	0.00116	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—sarcoma	0.000759	0.00113	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—sarcoma	0.000755	0.00112	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—sarcoma	0.000741	0.0011	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—sarcoma	0.000731	0.00109	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—sarcoma	0.000707	0.00105	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—sarcoma	0.000686	0.00102	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—sarcoma	0.000683	0.00102	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—sarcoma	0.000676	0.00101	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—sarcoma	0.000657	0.000977	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—sarcoma	0.000654	0.000973	CcSEcCtD
Alfuzosin—Rash—Epirubicin—sarcoma	0.000651	0.000969	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—sarcoma	0.000651	0.000968	CcSEcCtD
Alfuzosin—Headache—Epirubicin—sarcoma	0.000647	0.000963	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—sarcoma	0.000632	0.00094	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—sarcoma	0.000613	0.000913	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—sarcoma	0.000608	0.000904	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—sarcoma	0.000603	0.000897	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—sarcoma	0.000602	0.000896	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—sarcoma	0.000599	0.000891	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—sarcoma	0.000568	0.000845	CcSEcCtD
